Product Information
PIOGLITAZONE-GLIMEPIRIDE 30-2 is a generic product labeled by Prasco Laboratories, priced at $10.7597 per EA under NDC 66993082130. Its NADAC has been published 185 times since Oct 7, 2015.
FDA first approved this application on Jul 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2; 30 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993082130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021925FDA Approved
7/28/2006
TE Code
AB
On Market Since
8/4/2015
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has been published 185 times since Oct 7, 2015, and over the history we have for it it has risen 18.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7597 per EA |
|---|---|
| All-time high | $11.3091 (Jan 10, 2018) |
| All-time low | $7.2022 (Aug 21, 2024) |
| 52-week high | $10.8009 |
| 52-week low | $10.5207 |
| Median price | $10.5207 |
| Average price | $10.0801 |
| Largest weekly change | -36.3% (Aug 21, 2024) |
| Weeks tracked | 185 |
| Tracking since | Oct 7, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-GLIMEPIRIDE 30-2?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-GLIMEPIRIDE 30-2, manufactured by Prasco Laboratories, is $10.7597 per EA (NDC 66993082130), effective Aug 19, 2026.
How has the price of PIOGLITAZONE-GLIMEPIRIDE 30-2 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has risen 18.3%. It has been tracked across 185 weekly CMS publications since Oct 7, 2015.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-GLIMEPIRIDE 30-2?
Since Oct 7, 2015, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has ranged from a low of $7.2022 (Aug 21, 2024) to a high of $11.3091 (Jan 10, 2018), with a median of $10.5207 per EA.
Are there cheaper alternatives to PIOGLITAZONE-GLIMEPIRIDE 30-2?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-GLIMEPIRIDE 30-2 in a comparable dosage form, but none are currently priced below it.
Who manufactures PIOGLITAZONE-GLIMEPIRIDE 30-2?
PIOGLITAZONE-GLIMEPIRIDE 30-2 (NDC 66993082130) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.